Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/39723
Title: Novel potential predictive markers of sunitinib outcomes in long-term responders versus primary refractory patients with metastatic clear-cell renal cell carcinoma.
Authors: 
Keywords: 
Mesh: 
Issue Date: 2-May-2017
Citation: Oncotarget.2017 May;(8)18:30410-30421
Abstract: Several potential predictive markers of efficacy of targeted agents in patients with metastatic renal cell carcinoma (mRCC) have been identified. Interindividual heterogeneity warrants further investigation.
PMID: 28423742
URI: https://hdl.handle.net/20.500.12530/39723
Rights: openAccess
Appears in Collections:Hospitales > H. U. 12 de Octubre > Artículos
Fundaciones e Institutos de Investigación > IIS H. U. 12 de Octubre > Artículos
Fundaciones e Institutos de Investigación > IIS H. U. Clínico San Carlos > Artículos

Files in This Item:
File Description SizeFormat 
PMC5444752.pdf5.47 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.